# Enliven Therapeutics, Inc.: Form 8-K, filed Jun 25, 2025

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: 8-K
- Filed: 2025-06-25
- Accepted by EDGAR: Jun 25, 2025, 16:05 ET
- Period: 2025-06-24
- Accession: 0001193125-25-146874
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000119312525146874/d80015d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000119312525146874/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000119312525146874/d80015d8k.htm

Filed Jun 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-146874. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.
